Pharmacologic regulation of histamine release by the human recombinant histamine-releasing factor

Journal of Allergy and Clinical Immunology

Volumn 103, Issue 5 II, 1999, Pages 937-943

  Bheekha Escura, Roy ^a   Chance, Stacy R ^a   Langdon, Jacqueline M ^a   MacGlashan Jr , Donald W ^a   MacDonald, Susan M ^a  

^a JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

Histamine releasing factor; Human basophils; IgE heterogeneity; Pharmacologic regulation

Indexed keywords

HISTAMINE; HISTAMINE RELEASING AGENT; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN E RECEPTOR; RECOMBINANT HISTAMINE RELEASING FACTOR; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ALLERGY; ARTICLE; BASOPHIL; HISTAMINE RELEASE; HUMAN; HUMAN CELL; MEDIATOR RELEASE; MOLECULAR CLONING; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

EID: 0033032972     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0091-6749(99)70442-2     Document Type: Article

References (28)

1. Thueson D, Speck L, Lett-Brown M, Grant J. Histamine-releasing activity (HRF). I. Production by mitogen- or antigen-stimulated human mononuclear cells. J Immunol 1979;123:626-31.
2. Bischoff SC, Krieger M, Brunner T, et al. RANTES and related chemokines activate human basophil granulocytes through different G protein-coupled receptors. Eur J Immunol 1993;23:761-7.
3. Kuna P, Reddigari SR, Rucinski D, Oppenheim JJ, Kaplan AP. Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils. J Exp Med 1992;175:489-93.
4. Kuna P, Reddigari SR, Schall TJ, Rucinski D, Sadick M, Kaplan AP. Characterization of the human basophil response to cytokines, growth factors, and histamine releasing factors of the intercrine/chemokine family. J Immunol 1993;150:1932-43.
5. MacDonald SM, Schleimer RP, Kagey-Sobotka A, Gillis S, Lichtenstein LM. Recombinant IL-3 induces histamine release from human basophils. J Immunol 1989;142:3527-32.
6. Baeza ML, Reddigari S, Haak-Frendscho M, Kaplan AP. Purification and further characterization of human mononuclear cell histamine-releasing factor. J Clin Invest 1989;83:1204-10.
7. MacDonald SM, Rafnar T, Langdon J, Lichtenstein LM. Molecular identification of an IgE-dependent histamine-releasing factor. Science 1995;269:688-90.
8. Warner JA, Pienkowski MM, Plaut M, Norman PS, Lichtenstein LM. Identification of histamine releasing factor(s) in the late phase of cutaneous IgE-mediated reactions. J Immunol 1986;136:2583-7.
9. Schulman ES, Liu MC, Proud D, MacGlashan DW Jr, Lichtenstein LM, Plaut M. Human lung macrophages induce histamine release from basophils and mast cells. Am Rev Respir Dis 1985;131:230-5.
10. Sampson HA, Broadbent KR, Bernhisel-Broadbent J. Spontaneous release of histamine from basophils and histamine-releasing factor in patients with atopic dermatitis and food hypersensitivity. N Engl J Med 1989;321:228-32.
11. MacDonald SM, Lichtenstein LM, Proud D, et al. Studies of IgE-dependent histamine releasing factors: heterogeneity of IgE. J Immunol 1987;139:506-12.
12. Schroeder JT, Lichtenstein LM, MacDonald SM. An immunoglobulin E-dependent recombinant histamine-releasing factor induces interleukin-4 secretion from human basophils. J Exp Med 1996;183:1265-70.
13. Schroeder JT, Lichtenstein LM, MacDonald SM. Recombinant histamine-releasing factor enhances IgE-dependent IL-4 and IL-13 secretion by human basophils. J Immunol 1997;159:447-52.
14. Vercelli D. Regulation of IgE synthesis in humans. J Biol Regul Homeost Agents 1995;9:1-6.
15. Kinet JP, Jouvin MH, Paolini R, Numerof R, Scharenberg A. IgE receptor (FcεRI) and signal transduction. Eur Respir J Suppl 1996;22:116s-8s.
16. Warner JA, Yancey KB, MacGlashan DW Jr. The effect of pertussis toxin on mediator release from human basophils. J Immunol 1987;139:161-5.
17. Neer EJ. Heterotrimeric G proteins: organizers of transmembrane signals. Cell 1995;80:249-57.
18. Gschwendt M, Muller HJ, Kielbassa K, et al. Rottlerin, a novel protein kinase inhibitor. Biochem Biophys Res Commun 1994;199:93-8.
19. Bit RA, Davis, PD, Elliott LH, et al. Inhibitors of protein kinase C. 3. Potent and highly selective bisindolylmaleimides by conformational restriction. J Med Chem 1993;36:21-9.
20. Martiny-Baron G, Kazanietz MG, Mischak H, et al. Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J Biol Chem 1993;268:9194-7.
21. Gilbert HS, Ornstein L. Basophil counting with a new staining method using alcian blue. Blood 1975;46:279-86.
22. Siraganian RP. Refinements in the automated fluorometric histamine analysis system. J Immunol Methods 1975;7:283-90.
23. Warner JA, MacGlashan DW Jr. Signal transduction events in human basophils - a comparative study of the role of protein kinase-C in basophils activated by anti-IgE antibody and formyl-methionyl-leucylphenylalanine. J Immunol 1990;145:1897-905.
24. Gschwendt M, Kittstein W, Marks F. Elongation factor-2 kinase: effective inhibition by the novel protein kinase inhibitor rottlerin and relative insensitivity towards staurosporine. FEBS Lett 1994;338:85-8.
25. Bergstrand H, Lundquist B, Karabelas K, Michelsen P. Modulation of human basophil histamine release by protein kinase C inhibitors differs with secretagogue and with inhibitor. J Pharmacol Exp Ther 1992;260:1028-37.
26. Qatsha KA, Rudolph C, Marme D, Schachtele C, May WS. Go 6976, a selective inhibitor of protein kinase C, is a potent antagonist of human immunodeficiency virus 1 induction from latent/low-level-producing reservoir cells in vitro. Proc Natl Acad Sci USA 1993;90:4674-8.
27. Weber M, Dahinden CA. Basophil and eosinophil activation by CC chemokines. Int Arch Allergy Immunol 1995;107:148-50.
28. MacDonald SM, White JM, Kagey-Sobotka A, MacGlashan DW Jr, Proud DP, Lichtenstein LM. The heterogeneity of human IgE exemplified by the passive transfer of D20 sensitivity. Clin Exp Allergy 1991;21:133-8.